The long-term goal of this research is to elucidate the underlying mechanisms by which phenolic compounds present in the human diet influence tumorigenesis. Ongoing studies demonstrates that the oxidative metabolism of alkylphenols by cytochromes P450 lead, in many cases, to the formation of quinoid products capable of covalent binding and/or free radical generation in cells. We now propose to extend this work to investigate the involvement of such reactive metabolites in tumor promotion utilizing the most thoroughly characterized model for probing mechanistic aspects of promotion in the lung. This system involves the enhancement of lung tumor development by chronic administration of the food additive butylated hydroxytoluene (BHT) to carcinogen-initiated mice. It has been demonstrated that metabolism of BHT in the target organ is necessary for promotion and it is known that BHT is converted to reactive quinoid metabolites in lung. These findings lead to the hypothesis that promotion depends upon two successive P450 catalyzed oxidations to the ultimate promoting species, a strongly electrophilic quione methide which alkylates one or more critical proteins leading to a disruption of growth control mechanisms. The following specific aims are proposed: (1) Determine the role of metabolism in the differential responsiveness of promotion- sensitive (B+) and promotion-resistant (B-) mice to the lung tumor promoter BHT. Conversion of BHT to a quinone methide and other reactive metabolites, as well as the detoxification of reactive metabolites, will be examined in lung tissues and cells from B+ and B- mice. (2) Investigate alkylation targets of a BHT-derived quinone methide in lung cells that directly or indirectly impair cell-cell signaling. Protein alkylation by a highly reactive quinone methide metabolite of BHT will be examined in cells isolated from the lungs of B= and B- mice, and in tumorigenic and non-tumorigenic cell lines derived from murine lung. Alkylation patterns will be compared by radiochemical and immunochemical methods and selected adducts identified by mass spectrometry and microsequencing. (3) Examine biochemical consequences and oxidative damage in lung cells exposed to reactive metabolites of BHT. Isolated cells from B+ and B- mice and cell lines will be treated with reactive quinoid metabolites of BHT to investigate cytotoxicity, oxidative damage, inhibition of mitochondrial function, and inhibition of enzymes involved in detoxification.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA041248-15
Application #
6341884
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Kopelovich, Levy
Project Start
1994-09-30
Project End
2002-12-31
Budget Start
2001-01-01
Budget End
2001-12-31
Support Year
15
Fiscal Year
2001
Total Cost
$217,985
Indirect Cost
Name
University of Colorado Denver
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Shearn, Colin T; Fritz, Kristofer S; Thompson, John A (2011) Protein damage from electrophiles and oxidants in lungs of mice chronically exposed to the tumor promoter butylated hydroxytoluene. Chem Biol Interact 192:278-86
Shearn, Colin T; Fritz, Kristofer S; Meier, Brent W et al. (2008) Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro. Chem Res Toxicol 21:1631-41
Meier, Brent W; Gomez, Jose D; Kirichenko, Oleg V et al. (2007) Mechanistic basis for inflammation and tumor promotion in lungs of 2,6-di-tert-butyl-4-methylphenol-treated mice: electrophilic metabolites alkylate and inactivate antioxidant enzymes. Chem Res Toxicol 20:199-207
Meier, Brent W; Gomez, Jose D; Zhou, Angela et al. (2005) Immunochemical and proteomic analysis of covalent adducts formed by quinone methide tumor promoters in mouse lung epithelial cell lines. Chem Res Toxicol 18:1575-85
Lemercier, Jean-Noel; Meier, Brent W; Gomez, Jose D et al. (2004) Inhibition of glutathione S-transferase P1-1 in mouse lung epithelial cells by the tumor promoter 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT-quinone methide): protein adducts investigated by electrospray mass spectrometry. Chem Res Toxicol 17:1675-83
Sun, Yude; Dwyer-Nield, Lori D; Malkinson, Alvin M et al. (2003) Responses of tumorigenic and non-tumorigenic mouse lung epithelial cell lines to electrophilic metabolites of the tumor promoter butylated hydroxytoluene. Chem Biol Interact 145:41-51
Kupfer, Rene; Dwyer-Nield, Lori D; Malkinson, Alvin M et al. (2002) Lung toxicity and tumor promotion by hydroxylated derivatives of 2,6-di-tert-butyl-4-methylphenol (BHT) and 2-tert-butyl-4-methyl-6-iso-propylphenol: correlation with quinone methide reactivity. Chem Res Toxicol 15:1106-12
Kupfer, R; Liu, S Y; Allentoff, A J et al. (2001) Comparisons of hydroperoxide isomerase and monooxygenase activities of cytochrome P450 for conversions of allylic hydroperoxides and alcohols to epoxyalcohols and diols: probing substrate reorientation in the active site. Biochemistry 40:11490-501
Thompson, J A; Carlson, T J; Sun, Y et al. (2001) Studies using structural analogs and inbred strain differences to support a role for quinone methide metabolites of butylated hydroxytoluene (BHT) in mouse lung tumor promotion. Toxicology 160:197-205
Dwyer-Nield, L D; Thompson, J A; Peljak, G et al. (1998) Selective induction of apoptosis in mouse and human lung epithelial cell lines by the tert-butyl hydroxylated metabolite of butylated hydroxytoluene: a proposed role in tumor promotion. Toxicology 130:115-27

Showing the most recent 10 out of 19 publications